Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants
Clinical trial NCT04896632 · TERMINATED
Trial details
- NCT number
- NCT04896632
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2022-11-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.